These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27793695)

  • 1. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
    Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
    Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
    Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
    J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
    Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.
    Kundu J; Wahab SM; Kundu JK; Choi YL; Erkin OC; Lee HS; Park SG; Shin YK
    Int J Oncol; 2012 Sep; 41(3):839-48. PubMed ID: 22710759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.
    Shi R; Yang Z; Liu W; Liu B; Xu Z; Zhang Z
    Oncol Rep; 2014 Feb; 31(2):812-8. PubMed ID: 24297051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
    Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
    Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
    Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
    Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
    Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
    Feng X; Jiang J; Sun L; Zhou Q
    Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
    Chen L; Xu M; Zhong W; Hu Y; Wang G
    Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway.
    Pan J; Fan Z; Wang Z; Dai Q; Xiang Z; Yuan F; Yan M; Zhu Z; Liu B; Li C
    J Exp Clin Cancer Res; 2019 Feb; 38(1):52. PubMed ID: 30717785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
    Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
    Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
    Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.